Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 194

The DOI matches its Crossref record.

RESULTS OF OUR FIRST NINE INTRAPORTAL ISLET ALLOGRAFTS IN TYPE 1, INSULIN-DEPENDENT DIABETIC PATIENTS

SCHARP, DAVID W., LACY, PAUL E., SANTIAGO, JULIO V., MCCULLOUGH, CHRISTOPHER S., WEIDE, LAMONT G., BOYLE, PATRICK J., FALQUI, LUCA, MARCHETTI, PIERO, RICORDI, CAMILLO, GINGERICH, RONALD L., JAFFE, ALLAN S., CRYER, PHILIP E., HANTO, DOUGLAS W., ANDERSON, CHARLES B., FLYE, M. WAYNE · 1991 · Transplantation

Abstract

With the first demonstration of insulin independence following intraportal islet transplantation into a patient with type 1 diabetes, a new era of clinical islet transplantation will begin. This report provides our initial experience of clinical islet transplantation with a total of nine consecutive portal vein islet transplants in seven diabetic recipients. The first three transplants were done in nonrenal failure diabetics (NRFI) using 6319 +/- 2173 islets/kg body weight with islets processed from single pancreas and cultured for 7 days at 24 degrees C. Prednisone, azathioprine, and cyclosporine were initiated prior to transplant. While all three recipients demonstrated C-peptide function posttransplant, all three rejected their grafts at 2 weeks. Five days of OKT3 treatment failed to recover more than 10% of their rejecting islet grafts. The studies were then shifted to established kidney transplant recipients (EKI) maintaining their basal immunosuppression while adding 7 days of Minnesota antilymphoblast globulin (MALG) to the recipient using islets from single donor pancreas that had been cultured for 7 days at 24 degrees C. There were an average of 6161 +/- 911 islets transplanted intraportally into three EKI recipients. All three had C-peptide response from the transplant, but none achieved insulin independence. While the first patient rejected his graft at 2 weeks, two recipients demonstrated long-term islet function up to 10 months posttransplant. Sustacal challenge testing demonstrated C-peptide responsiveness, but in a delayed pattern suggesting insufficient islet mass had been transplanted. The next three kidney transplant recipients received islets from more than one donor pancreas averaging 13,916 +/- 556 islets/kg body weight. The first of these was the first to achieve insulin independence from 10 to day 25 posttransplant when she appeared to have a rejection episode. The second and third recipients were retransplanted with islets from multiple donors having achieved partial islet function from single pancreas donor. The first patient on triple immunosuppression is demonstrating long-term partial function at 184 days but is not insulin independent. The third patient on prednisone and azathioprine received one half his islets after 7-day culture and the other half after 7-day culture combined with cryopreservation. He is continuing to demonstrate insulin independence for 154 days post-transplant with a glycated hemoglobin value of 5.6%. Sustacal challenge data demonstrate a total stimulated C-peptide response of 155 rhomol/ml at 4 months post-transplant compared with 148 +/- 12 rhomol/ml for normal controls (NC) and 425 rhomol/ml for nondiabetic, established kidney transplant recipients on triple immunosuppression.(ABSTRACT TRUNCATED AT 400 WORDS)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00007890-199101000-00012

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 194

Metadata

Authors
SCHARP, D. W., LACY, P. E., SANTIAGO, J. V., MCCULLOUGH, C. S., WEIDE, L. G., BOYLE, P. J., FALQUI, L., MARCHETTI, P., RICORDI, C., GINGERICH, R. L., JAFFE, A. S., CRYER, P. E., HANTO, D. W., ANDERSON, C. B., & FLYE, M. W.
Venue
Transplantation
Published
1991-01
Volume
51
Issue
1
Pages
76-85
ISSN
0041-1337 (ISSN-L)
OpenAlex
W1993326517
Cited by
194
References
0
FWCI
22.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RESULTS OF OUR FIRST NINE INTRAPORTAL ISLET ALLOGRAFTS IN TYPE 1, INSULIN-DEPENDENT DIABETIC PATIENTS. https://app.cochat.ai/papers/10.1097/00007890-199101000-00012
The paper
SCHARP, D. W., LACY, P. E., SANTIAGO, J. V., MCCULLOUGH, C. S., WEIDE, L. G., BOYLE, P. J., FALQUI, L., MARCHETTI, P., RICORDI, C., GINGERICH, R. L., JAFFE, A. S., CRYER, P. E., HANTO, D. W., ANDERSON, C. B., & FLYE, M. W. (1991). RESULTS OF OUR FIRST NINE INTRAPORTAL ISLET ALLOGRAFTS IN TYPE 1, INSULIN-DEPENDENT DIABETIC PATIENTS. Transplantation. https://doi.org/10.1097/00007890-199101000-00012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.